Enhanced growth of tumour cells in healing colonie anastomoses and laparotomy wounds
- 1 September 1989
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 4 (3) , 172-177
- https://doi.org/10.1007/bf01649697
Abstract
In the past, it has been noted that experimental tumour cells innoculated into the peritoneal cavity or into the lumen of the bowel will grow at a recently formed colonic anastomosis. However, it has previously been unclear whether the healing process enhances tumour growth or whether the presence of a suture line merely allows the tumour cells to gain access to the tissues. In the present study, using the hooded Lister rat, we have confirmed these findings by showing that growth of the syngeneic MC28 sarcoma and OES5 breast carcinoma occurs preferentially at colonic anastomoses and laparotomy wounds after intraperitoneal injection, and at colonic anastomoses after intraluminal injection. In previous studies using the MC28 sarcoma and the OES5 breast carcinoma injected by the intracardiac route (so that tumour cells reach normal and healing tissues in approximately equal numbers) we have shown that tumour growth is enhanced in healing wounds but not in the surrounding normal tissues when cells reach a healing colonic anastomosis or laparotomy wound within 2 h of its formation. Furthermore, by studying the distribution of radiolabelled tumour cells after intracardiac injection, we have calculated that the probability of a tumour cell leading to a deposit in a healing anastomosis or laparotomy wound is increased 1,000 fold compared to normal tissue. No previous studies have combined the data for intracardiac, intraluminal and intraperitoneal injection of tumour cells using the same animal model. We conclude that the same phenomenon of tumour growth enhancement in colonic anastomoses and laparotomy wounds reported after intracardiac injection of tumour cells may well be enhancing tumour growth after intraperitoneal and intraluminal injection. If these results can be extrapolated to man, then tumour cells spilled at surgery for colorectal cancer (or indeed any other cancer) may well encounter an environment which favours their growth and so the healing process itself may contribute to the genesis of local recurrence of malignant disease.This publication has 21 references indexed in Scilit:
- Exfoliated cells and in vitro growth in colorectal cancerBritish Journal of Surgery, 1987
- Surgery for malignant melanoma: From which limb should the graft be taken?British Journal of Surgery, 1986
- RECURRENCE AND SURVIVAL AFTER TOTAL MESORECTAL EXCISION FOR RECTAL CANCERThe Lancet, 1986
- Proliferative and Metastatic Potential of Exfoliated Colorectal Cancer CellsJNCI Journal of the National Cancer Institute, 1986
- Local recurrence after potentially curative resection for rectal cancer in a series of 1008 patientsBritish Journal of Surgery, 1985
- Viability of exfoliated colorectal carcinoma cellsBritish Journal of Surgery, 1984
- Local recurrence following ‘curative’ surgery for large bowel cancer: I. The overall pictureBritish Journal of Surgery, 1984
- The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?British Journal of Surgery, 1982
- Implantation in cancer of the colon.1967
- ON THE CAUSE OF THE LOCALIZATION OF SECONDARY TUMORS AT POINTS OF INJURYThe Journal of Experimental Medicine, 1914